North East and North Cumbria
ICS Formulary
2 Cardiovascular system
02-08 Anticoagulants and protamine
Defibrotide
Formulary
Approved for use in severe veno-occlusive disease following stem cell transplant - in accordance with NHS England commissioning policy.
Use of defibrotide in severe venoocclusive disease following stem cell transplant
Idarucizumab
Formulary
Approved for use as a rapid reversal agent for dabigatran.
Links
Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
NICE NG148: Acute kidney injury: prevention, detection and management
NICE NG191: COVID-19 rapid guideline: managing COVID-19
Use of defibrotide in severe venoocclusive disease following stem cell transplant
Key
Full Site